Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center

Lignende værker

• The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation
  af: Osadnik, Tadeusz, et al.
  Udgivet: (2015)
• The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
  af: Osadnik, Tadeusz, et al.
  Udgivet: (2017)
• The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent
  af: Osadnik, Tadeusz, et al.
  Udgivet: (2016)
• Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease
  af: Osadnik, Tadeusz, et al.
  Udgivet: (2013)
• The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease
  af: Osadnik, Tadeusz, et al.
  Udgivet: (2016)